Jul 23, 2008
Story Timeline: 79 days
Wednesday July 23, 5:06 pm ET Drug maker Eli Lilly to announce earnings Thursday from second quarter filled with bumps INDIANAPOLIS (AP) -- Drug maker Eli Lilly and Co. reports second-quarter earnings Thursday before the stock market opens. The following is a summary of key developments related to the period. OVERVIEW: The Food and Drug Administration dealt Lilly a setback during the quarter when the company announced June 24 that regulators needed three more months to review the blood thinner prasugrel. Lilly and its Japanese partner, Daiichi Sankyo Co., hope to gain approval of the drug prasugrel to treat patients with acute coronary syndromes, such as heart attacks or unstable angina, who are at risk of developing blood clots. If approved, prasugrel would compete against the blockbuster Plavix, made by Bristol-Myers Squibb...
[read full story]